Fulcrum Therapeutics files an amended Schedule 13G, showing no change in stock ownership, reflecting stability in the pharmaceutical preparations sector.
| Name | Fulcrum Therapeutics, Inc. |
|---|---|
| CIK | 0001680581 |
| Tickers | FULC |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 474839948 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-651-8851 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Fulcrum Therapeutics files an amended Schedule 13G, showing no change in stock ownership, reflecting stability in the pharmaceutical preparations sector.
Fulcrum Therapeutics receives SEC approval for S-4 registration, enhancing its funding capabilities for pharmaceutical developments.
Fulcrum Therapeutics has filed an amendment for its merger with Slate Medicines, marking a pivotal move in the pharmaceutical preparations sector.
Bank of America now holds 1.5% of Fulcrum Therapeutics, indicating strategic investment shifts in the pharmaceutical preparations sector.
Fulcrum Therapeutics has filed an amended registration for its merger with Slate Medicines, potentially reshaping the pharmaceutical preparations landscape.
527 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128728 | 005-91080 | 261563803 | 34 | 14560 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000935836-26-000588 | 005-91080 | 261559310 | 34 | 15696 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-127211 | 005-91080 | 261553886 | 34 | 11110 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-007765 | 005-91080 | 261552307 | 34 | 16770 | |||
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458453 | 001-38978 | 261547208 | 34 | 9505244 | 1 | 1 | |
| 2026-11-12 | 425 | 425 | 0001193125-26-458402 | 001-38978 | 261547058 | 34 | 30112 | |||
| 2026-11-12 | 8-K | 8-K | 8.01 | 0001193125-26-458387 | 001-38978 | 261547021 | 34 | 150756 | 1 | 1 |
| 2026-11-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003437 | 333-298705 | 261524410 | 33 | 1718 | ||
| 2026-11-04 | 424B3 | 424B3 | 0001193125-26-447368 | 333-298705 | 261522757 | 33 | 7826305 | |||
| 2026-11-03 | S-4/A | S-4/A | 0001193125-26-444432 | 333-298705 | 261514462 | 33 | 7895301 | |||
| 2026-10-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000532 | 005-91080 | 261494980 | 34 | 171387 | |||
| 2026-10-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002052113-26-001118 | 005-91080 | 261490522 | 34 | 10901 | |||
| 2026-10-20 | S-4/A | S-4/A | 0001193125-26-426840 | 333-298705 | 261473577 | 33 | 8247414 | |||
| 2026-10-08 | S-4/A | S-4/A | 0001193125-26-418056 | 333-298705 | 261450518 | 33 | 7928549 | |||
| 2026-09-02 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-379476 | 001-38978 | 261352848 | 33 | 7954 | |||
| 2026-09-02 | S-4 | S-4 | 0001193125-26-379106 | 333-298705 | 261352507 | 33 | 21938358 | 1 | 1 | |
| 2026-08-17 | 425 | 425 | 0001193125-26-354107 | 001-38978 | 261286950 | 34 | 155376 | |||
| 2026-08-17 | 425 | 425 | 0001193125-26-353282 | 001-38978 | 261284929 | 34 | 31109 | |||
| 2026-08-17 | 425 | 425 | 0001193125-26-353280 | 001-38978 | 261284925 | 34 | 15540059 | |||
| 2026-08-17 | 8-K | 8-K | 1.01,3.02,5.01,5.02,7.01,9.01 | 0001193125-26-353278 | 001-38978 | 261284911 | 34 | 15992961 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000923 | 005-91080 | 261283022 | 34 | 12714 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097278 | 005-91080 | 261282895 | 34 | 10714 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005528 | 005-91080 | 261282219 | 34 | 16910 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352345 | 005-91080 | 261282161 | 34 | 12559 | |||
| 2026-08-10 | 8-K | 8-K | 5.02 | 0001193125-26-341385 | 001-38978 | 261256395 | 34 | 148250 | 1 | 1 |
| 2026-08-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000396 | 005-91080 | 261231372 | 34 | 171237 | |||
| 2026-07-30 | 10-Q | 10-Q | 0001193125-26-326098 | 001-38978 | 261223271 | 34 | 9969965 | 1 | 1 | |
| 2026-07-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002576 | 005-91080 | 261212598 | 34 | 10837 | |||
| 2026-07-20 | 4 | xslF345X06/form4-07212026_010750.xml | 0001178579-26-000016 | 9415 | ||||||
| 2026-07-17 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002052113-26-000745 | 005-91080 | 261182518 | 34 | 10849 | |||
| 2026-07-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-008613 | 005-91080 | 261178416 | 34 | 14398 | |||
| 2026-07-15 | 4 | xslF345X06/form4-07152026_110717.xml | 0001178579-26-000014 | 12823 | ||||||
| 2026-07-15 | 3 | xslF345X06/form3-07152026_110708.xml | 0001178579-26-000013 | 6368 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294703 | 5442 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294699 | 5437 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294697 | 5451 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294692 | 5456 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294691 | 5452 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294690 | 5456 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294683 | 5382 | ||||||
| 2026-07-02 | 4 | 4 | 0001193125-26-294680 | 5451 | ||||||
| 2026-06-30 | 4 | 4 | 0001193125-26-290622 | 5283 | ||||||
| 2026-06-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006549 | 001-38978 | 261129778 | 33 | 4725 | |||
| 2026-06-25 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000935836-26-000331 | 005-91080 | 261123366 | 34 | 15798 | |||
| 2026-06-25 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000935836-26-000330 | 005-91080 | 261123311 | 34 | 15798 | |||
| 2026-06-25 | 8-K | 8-K | 5.07 | 0001193125-26-282873 | 001-38978 | 261122388 | 34 | 145866 | 1 | 1 |
| 2026-06-11 | 8-K | 8-K | 5.02 | 0001193125-26-267659 | 001-38978 | 261083512 | 34 | 153361 | 1 | 1 |
| 2026-06-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-007338 | 005-91080 | 261080932 | 34 | 27487 | |||
| 2026-06-04 | 8-K | 8-K | 2.05,8.01 | 0001193125-26-257376 | 001-38978 | 261064889 | 34 | 157683 | 1 | 1 |
| 2026-06-01 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-251394 | 001-38978 | 261050668 | 34 | 251343 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062675 | 005-91080 | 26988792 | 34 | 10907 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-226891 | 005-91080 | 26988271 | 34 | 12846 | |||
| 2026-05-01 | 4 | 4 | 0001193125-26-201468 | 5346 | ||||||
| 2026-05-01 | 3 | 3 | 0001193125-26-201437 | 17799 | ||||||
| 2026-04-30 | DEFA14A | DEFA14A | 0001193125-26-197308 | 001-38978 | 26925467 | 34 | 1755161 | |||
| 2026-04-30 | ARS | ARS | 0001193125-26-197291 | 001-38978 | 26925408 | 34 | 1142156 | |||
| 2026-04-30 | DEF 14A | DEF 14A | 0001193125-26-197196 | 001-38978 | 26925151 | 34 | 11392187 | 1 | 1 | |
| 2026-04-27 | 10-Q | 10-Q | 0001193125-26-178814 | 001-38978 | 26896483 | 34 | 8646183 | 1 | 1 | |
| 2026-04-27 | 8-K | 8-K | 1.02,2.02,5.02,9.01 | 0001193125-26-178806 | 001-38978 | 26896472 | 34 | 343396 | 1 | 1 |
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001344 | 005-91080 | 26800240 | 34 | 7089 | |||
| 2026-02-24 | S-8 | S-8 | 0001193125-26-065206 | 333-293670 | 26667509 | 33 | 184000 | 1 | 1 | |
| 2026-02-24 | 10-K | 10-K | 0001193125-26-065197 | 001-38978 | 26667450 | 34 | 12322448 | 1 | 1 | |
| 2026-02-24 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-065190 | 001-38978 | 26667435 | 34 | 367135 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-26-000043 | 005-91080 | 26642098 | 34 | 15443 | |||
| 2026-02-04 | 4/A | 4/A | 0001193125-26-037606 | 5357 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037576 | 5315 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037574 | 5312 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037573 | 5148 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037575 | 5332 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037572 | 5410 | ||||||
| 2026-01-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-009845 | 001-38978 | 26524787 | 34 | 15722726 | 1 | 1 |
| 2026-01-06 | 4 | 4 | 0001193125-26-004572 | 5148 | ||||||
| 2025-12-17 | 4 | 4 | 0001193125-25-322740 | 4768 | ||||||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010350 | 001-38978 | 251572052 | 33 | 4884 | |||
| 2025-12-11 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-314728 | 001-38978 | 251563349 | 34 | 1093561 | 1 | 1 |
| 2025-12-11 | 424B5 | 424B5 | 0001193125-25-314724 | 333-277419 | 251563347 | 33 | 578438 | |||
| 2025-12-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-25-000068 | 005-91080 | 251562498 | 34 | 14878 | |||
| 2025-12-10 | 4 | xslF345X05/form4-12102025_091221.xml | 0001231919-25-000596 | 15141 | ||||||
| 2025-12-10 | FWP | FWP | 0001193125-25-313415 | 333-277419 | 251560765 | 34 | 118218 | |||
| 2025-12-08 | 144 | xsl144X01/primary_doc.xml | 0001178937-25-000086 | 001-38978 | 251557093 | 33 | 5603 | |||
| 2025-12-08 | 424B5 | 424B5 | 0001193125-25-311359 | 333-277419 | 251556753 | 33 | 503929 | |||
| 2025-12-08 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-310509 | 001-38978 | 251554569 | 34 | 17730860 | 1 | 1 |
| 2025-11-21 | 4 | 4 | 0001193125-25-291392 | 5148 | ||||||
| 2025-11-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-009089 | 001-38978 | 251499602 | 33 | 4720 | |||
| 2025-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004883 | 005-91080 | 251475731 | 34 | 12391 | |||
| 2025-10-29 | 10-Q | 10-Q | 0001193125-25-254633 | 001-38978 | 251426805 | 34 | 10416099 | 1 | 1 | |
| 2025-10-29 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-254619 | 001-38978 | 251426791 | 34 | 376283 | 1 | 1 |
| 2025-10-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-002864 | 005-91080 | 251401977 | 34 | 10747 | |||
| 2025-08-28 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-190746 | 001-38978 | 251268808 | 34 | 15532036 | 1 | 1 |
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003497 | 005-91080 | 251204320 | 34 | 12321 | |||
| 2025-07-29 | 10-Q | 10-Q | 0000950170-25-099407 | 001-38978 | 251157787 | 34 | 10089530 | 1 | 1 | |
| 2025-07-29 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-25-099404 | 001-38978 | 251157774 | 34 | 16793735 | 1 | 1 |
| 2025-06-30 | 4 | 4 | 0000950170-25-091584 | 5319 | ||||||
| 2025-06-30 | 4 | 4 | 0000950170-25-091583 | 5300 | ||||||
| 2025-06-30 | 4 | 4 | 0000950170-25-091582 | 5316 | ||||||
| 2025-06-30 | 4 | 4 | 0000950170-25-091585 | 5312 | ||||||
| 2025-06-30 | 4 | 4 | 0000950170-25-091580 | 5245 | ||||||
| 2025-06-30 | 4 | 4 | 0000950170-25-091579 | 5305 | ||||||
| 2025-06-30 | 4 | 4 | 0000950170-25-091578 | 5311 | ||||||
| 2025-06-30 | 4 | 4 | 0000950170-25-091577 | 5314 | ||||||
| 2025-06-27 | 8-K | 8-K | 5.07 | 0001193125-25-151276 | 001-38978 | 251086452 | 34 | 148958 | 1 | 1 |
| 2025-05-09 | 4 | 4 | 0000950170-25-068038 | 5032 | ||||||
| 2025-05-07 | DEFR14A | DEFR14A | 0000950170-25-065795 | 001-38978 | 25922079 | 34 | 3870701 | |||
| 2025-05-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-002740 | 005-91080 | 25910222 | 34 | 16958 | |||
| 2025-05-01 | 10-Q | 10-Q | 0000950170-25-061442 | 001-38978 | 25899375 | 34 | 8995273 | 1 | 1 | |
| 2025-05-01 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-061439 | 001-38978 | 25899356 | 34 | 331350 | 1 | 1 |
| 2025-04-30 | ARS | ARS | 0000950170-25-061020 | 001-38978 | 25894829 | 34 | 4742888 | |||
| 2025-04-30 | DEFA14A | DEFA14A | 0000950170-25-061013 | 001-38978 | 25894784 | 34 | 1825937 | |||
| 2025-04-30 | DEF 14A | DEF 14A | 0000950170-25-061000 | 001-38978 | 25894715 | 34 | 3076087 | 1 | 1 | |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000745 | 005-91080 | 25844710 | 34 | 10746 | |||
| 2025-03-04 | 8-K | 8-K | 1.02 | 0000950170-25-032355 | 001-38978 | 25705882 | 34 | 185832 | 1 | 1 |
| 2025-02-25 | S-8 | S-8 | 0001193125-25-034249 | 333-285180 | 25659398 | 33 | 72451 | |||
| 2025-02-25 | 10-K | 10-K | 0000950170-25-026068 | 001-38978 | 25659378 | 34 | 13734550 | 1 | 1 | |
| 2025-02-25 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-026063 | 001-38978 | 25659341 | 34 | 370715 | 1 | 1 |
| 2025-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000860 | 005-91080 | 25612605 | 34 | 15610 | |||
| 2025-01-28 | 4 | 4 | 0000950170-25-009818 | 5315 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-009816 | 5413 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-009815 | 5335 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-009813 | 5318 | ||||||
| 2025-01-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-25-004942 | 001-38978 | 25524738 | 34 | 8225914 | 1 | 1 |
| 2025-01-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-000110 | 005-91080 | 25511961 | 34 | 16342 | |||
| 2024-12-23 | 8-K | 8-K | 1.02,9.01 | 0001193125-24-284214 | 001-38978 | 241574072 | 34 | 151330 | 1 | 1 |
| 2024-12-06 | SC 13G | us3596161097_120624.txt | 0002012383-24-004535 | 005-91080 | 241532638 | 34 | 13777 | |||
| 2024-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-24-119151 | 005-91080 | 241463827 | 34 | 10602 | |||
| 2024-11-14 | SC 13G/A | d11527936_13g-a.htm | 0000919574-24-006744 | 005-91080 | 241462919 | 34 | 123655 | |||
| 2024-11-14 | 4 | 4 | 0000950170-24-127074 | 5197 | ||||||
| 2024-11-14 | 3 | 3 | 0000950170-24-127055 | 13876 | ||||||
| 2024-11-14 | SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-24-006487 | 005-91080 | 241456863 | 34 | 63180 | |||
| 2024-11-13 | 10-Q | 10-Q | 0000950170-24-125931 | 001-38978 | 241451151 | 34 | 8941310 | 1 | 1 | |
| 2024-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-125927 | 001-38978 | 241451137 | 34 | 305044 | 1 | 1 |
| 2024-11-12 | 8-K | 8-K | 5.02 | 0001193125-24-256101 | 001-38978 | 241449954 | 34 | 146411 | 1 | 1 |
| 2024-11-12 | SC 13G/A | UnitedStates_13G__FulcrumThe.txt | 0000932471-24-001033 | 005-91080 | 241447583 | 34 | 6514 | |||
| 2024-11-08 | SC 13G | us3596161097_110824.txt | 0002012383-24-003431 | 005-91080 | 241439575 | 34 | 13775 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__FulcrumThe.txt | 0000932471-24-000432 | 005-91080 | 241421704 | 34 | 5574 | |||
| 2024-10-21 | SC 13G | us3596161097_102124.txt | 0002012383-24-000922 | 005-91080 | 241383510 | 34 | 13763 | |||
| 2024-10-07 | SC 13G/A | filing.txt | 0000315066-24-002025 | 005-91080 | 241356679 | 34 | 8238 | |||
| 2024-09-24 | 8-K | 8-K | 2.05,9.01 | 0000950170-24-109069 | 001-38978 | 241320217 | 34 | 175980 | 1 | 1 |
| 2024-09-23 | 3 | xslF345X02/form3-09232024_080926.xml | 0001415889-24-023836 | 11524 | ||||||
| 2024-09-20 | SC 13G | SC 13G | 0001193125-24-222915 | 005-91080 | 241313656 | 34 | 78227 | |||
| 2024-09-16 | SC 13G/A | SC 13G/A | 0001104659-24-100319 | 005-91080 | 241302306 | 34 | 82784 | |||
| 2024-09-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-217822 | 001-38978 | 241294410 | 34 | 182388 | 1 | 1 |
| 2024-08-23 | SC 13G/A | SC 13G/A | 0001104659-24-092442 | 005-91080 | 241236550 | 34 | 95421 | |||
| 2024-08-23 | 4 | xslF345X05/form4-08232024_040801.xml | 0001415889-24-022127 | 13794 | ||||||
| 2024-08-22 | 8-K | 8-K | 3.02,9.01 | 0001193125-24-205347 | 001-38978 | 241231971 | 34 | 242842 | 1 | 1 |
| 2024-07-31 | S-8 | S-8 | 0001193125-24-189503 | 333-281119 | 241159925 | 33 | 65830 | |||
| 2024-07-31 | 10-Q | 10-Q | 0000950170-24-088238 | 001-38978 | 241159878 | 34 | 10358808 | 1 | 1 | |
| 2024-07-31 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-088236 | 001-38978 | 241159867 | 34 | 305402 | 1 | 1 |
| 2024-07-08 | 4 | 4 | 0000950170-24-081949 | 7175 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074892 | 5321 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074888 | 5321 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074887 | 5326 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074885 | 5326 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074884 | 5307 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074883 | 5327 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074882 | 5313 | ||||||
| 2024-06-18 | 4 | 4 | 0000950170-24-074868 | 5124 | ||||||
| 2024-06-18 | 3 | 3 | 0000950170-24-074855 | 14777 | ||||||
| 2024-06-17 | 8-K | 8-K | 5.02,5.07 | 0001193125-24-162653 | 001-38978 | 241048839 | 34 | 158150 | 1 | 1 |
| 2024-05-13 | 10-Q | 10-Q | 0000950170-24-058193 | 001-38978 | 24936860 | 34 | 7746832 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 1.01,2.02,9.01 | 0000950170-24-058187 | 001-38978 | 24936843 | 34 | 266881 | 1 | 1 |
| 2024-05-09 | 4 | 4 | 0000950170-24-056947 | 4864 | ||||||
| 2024-04-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-25 16:30:00 | 9999999995-24-001122 | 333-277419 | 24878366 | 33 | 1724 | ||
| 2024-04-24 | CORRESP | filename1.htm | 0001193125-24-110274 | 5068 | ||||||
| 2024-04-19 | ARS | ARS | 0001193125-24-102886 | 001-38978 | 24857877 | 34 | 5956320 | |||
| 2024-04-19 | DEFA14A | DEFA14A | 0001193125-24-102877 | 001-38978 | 24857820 | 34 | 515653 | |||
| 2024-04-19 | DEF 14A | DEF 14A | 0001193125-24-102863 | 001-38978 | 24857732 | 34 | 1073956 | |||
| 2024-03-20 | 4 | 4 | 0000950170-24-034177 | 5497 | ||||||
| 2024-03-20 | 3 | 3 | 0000950170-24-034165 | 14341 | ||||||
| 2024-03-08 | 4 | 4 | 0000950170-24-028827 | 5143 | ||||||
| 2024-03-08 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-028824 | 001-38978 | 24735978 | 33 | 4580 | |||
| 2024-03-05 | 4 | 4 | 0000950170-24-025933 | 5061 | ||||||
| 2024-03-01 | UPLOAD | filename1.pdf | 0000000000-24-002379 | 333-277419 | 40299 | |||||
| 2024-02-27 | S-8 | S-8 | 0001193125-24-048113 | 333-277421 | 24688575 | 33 | 79688 | |||
| 2024-02-27 | S-3 | S-3 | 0001193125-24-048095 | 333-277419 | 24688389 | 33 | 1334349 | |||
| 2024-02-27 | 10-K | 10-K | 0000950170-24-021074 | 001-38978 | 24686353 | 34 | 11347446 | 1 | 1 | |
| 2024-02-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-020615 | 001-38978 | 24681914 | 34 | 274911 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023996 | 005-91080 | 24640161 | 34 | 80465 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036266 | 005-91080 | 24638636 | 34 | 143609 | |||
| 2024-02-14 | SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-24-001576 | 005-91080 | 24632394 | 34 | 65054 | |||
| 2024-02-13 | SC 13G/A | d10963156_13g-a.htm | 0000919574-24-000953 | 005-91080 | 24623844 | 34 | 121153 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001144 | 005-91080 | 24611655 | 34 | 8140 | |||
| 2024-02-07 | SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-24-001172 | 005-91080 | 24602192 | 34 | 101374 | |||
| 2024-01-30 | 4 | 4 | 0000950170-24-009096 | 7640 | ||||||
| 2024-01-30 | 4 | 4 | 0000950170-24-009094 | 5318 | ||||||
| 2024-01-30 | 4 | 4 | 0000950170-24-009092 | 5321 | ||||||
| 2024-01-19 | 4 | 4 | 0000950170-24-005790 | 5624 | ||||||
| 2023-11-07 | 10-Q | 10-Q | 0000950170-23-059755 | 001-38978 | 231381517 | 34 | 10479287 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-059753 | 001-38978 | 231381503 | 34 | 315325 | 1 | 1 |
| 2023-10-02 | 8-K | 8-K | 5.02 | 0001193125-23-249011 | 001-38978 | 231299558 | 34 | 142421 | 1 | 1 |
| 2023-08-22 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-217439 | 001-38978 | 231190956 | 34 | 5112430 | 1 | 1 |
| 2023-08-09 | 4 | 4 | 0000950170-23-040615 | 5382 | ||||||
| 2023-08-09 | 3 | 3 | 0000950170-23-040592 | 14143 | ||||||
| 2023-08-03 | 10-Q | 10-Q | 0000950170-23-037579 | 001-38978 | 231138035 | 34 | 10628891 | 1 | 1 | |
| 2023-08-03 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-23-037574 | 001-38978 | 231138012 | 34 | 359157 | 1 | 1 |
| 2023-07-10 | 8-K | 8-K | 1.01 | 0001193125-23-184748 | 001-38978 | 231080489 | 34 | 155225 | 1 | 1 |
| 2023-07-07 | SC 13G/A | us3596161097_070723.txt | 0001306550-23-009506 | 005-91080 | 231077205 | 34 | 12336 | |||
| 2023-07-03 | 3 | 3 | 0000950170-23-031405 | 15140 | ||||||
| 2023-06-29 | 4 | 4 | 0000950170-23-030765 | 5244 | ||||||
| 2023-06-29 | 4 | 4 | 0000950170-23-030757 | 5302 | ||||||
| 2023-06-29 | 4 | 4 | 0000950170-23-030758 | 5231 | ||||||
| 2023-06-29 | 4 | 4 | 0000950170-23-030756 | 5218 | ||||||
| 2023-06-29 | 4 | 4 | 0000950170-23-030755 | 5239 | ||||||
| 2023-06-29 | 4 | 4 | 0000950170-23-030753 | 5304 | ||||||
| 2023-06-29 | 4 | 4 | 0000950170-23-030752 | 5245 | ||||||
| 2023-06-26 | 10-K/A | 10-K/A | 0000950170-23-029693 | 001-38978 | 231038895 | 34 | 11202984 | 1 | 1 | |
| 2023-06-26 | 10-K/A | 10-K/A | 0000950170-23-029689 | 001-38978 | 231038871 | 34 | 9894278 | 1 | 1 | |
| 2023-06-23 | 10-K/A | 10-K/A | 0000950170-23-029682 | 001-38978 | 231038837 | 34 | 9714088 | 1 | 1 | |
| 2023-06-09 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-23-164435 | 001-38978 | 231005255 | 34 | 200713 | 1 | 1 |
| 2023-05-15 | 10-Q | 10-Q | 0000950170-23-021960 | 001-38978 | 23918353 | 34 | 9252902 | 1 | 1 | |
| 2023-05-15 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-23-021958 | 001-38978 | 23918346 | 34 | 326651 | 1 | 1 |
| 2023-05-11 | 4 | 4 | 0000950170-23-021245 | 4782 | ||||||
| 2023-04-28 | 4 | 4 | 0000950170-23-015832 | 5625 | ||||||
| 2023-04-28 | ARS | ARS | 0001193125-23-126993 | 001-38978 | 23866451 | 34 | 5985937 | |||
| 2023-04-28 | 4 | 4 | 0000950170-23-015824 | 5568 | ||||||
| 2023-04-28 | DEFA14A | DEFA14A | 0001193125-23-126931 | 001-38978 | 23866138 | 34 | 421930 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001193125-23-126856 | 001-38978 | 23865739 | 34 | 948648 | |||
| 2023-04-18 | PRE 14A | PRE 14A | 0001193125-23-104980 | 001-38978 | 23826866 | 34 | 917622 | |||
| 2023-04-05 | 8-K | 8-K | 5.02 | 0001193125-23-091620 | 001-38978 | 23801228 | 34 | 144602 | 1 | 1 |
| 2023-03-09 | S-8 | S-8 | 0001193125-23-065374 | 333-270385 | 23718277 | 33 | 69154 | |||
| 2023-03-09 | 10-K | 10-K | 0000950170-23-006841 | 001-38978 | 23718180 | 34 | 15441158 | 1 | 1 | |
| 2023-03-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-006834 | 001-38978 | 23718162 | 34 | 377967 | 1 | 1 |
| 2023-03-06 | SC 13G | FULCRUM THERAPEUTICS, INC. | 0000902664-23-002133 | 005-91080 | 23709455 | 34 | 109181 | |||
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #1 | 0000899140-23-000389 | 005-91080 | 23629493 | 34 | 60621 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-039067 | 005-91080 | 23629062 | 34 | 153868 | |||
| 2023-02-14 | SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-23-001712 | 005-91080 | 23623819 | 34 | 63918 | |||
| 2023-02-13 | 4 | FORM 4 SUBMISSION | 0000899243-23-004745 | 5436 | ||||||
| 2023-02-13 | 4 | FORM 4 SUBMISSION | 0000899243-23-004744 | 5438 | ||||||
| 2023-02-13 | 4 | FORM 4 SUBMISSION | 0000899243-23-004743 | 5493 | ||||||
| 2023-02-13 | 4 | FORM 4 SUBMISSION | 0000899243-23-004742 | 5443 | ||||||
| 2023-02-13 | SC 13G/A | d9928609_13g-a.htm | 0000919574-23-000956 | 005-91080 | 23615407 | 34 | 108285 | |||
| 2023-02-09 | SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-23-001349 | 005-91080 | 23604681 | 34 | 101812 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001651 | 005-91080 | 23602238 | 34 | 8061 | |||
| 2023-02-01 | SC 13G/A | us3596161097_020123.txt | 0001306550-23-006387 | 005-91080 | 23577465 | 34 | 13266 | |||
| 2023-01-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-006213 | 10407 | ||||||
| 2023-01-23 | SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 0001085146-23-000296 | 005-91080 | 23544096 | 34 | 27192 | |||
| 2023-01-18 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-23-010273 | 001-38978 | 23535109 | 34 | 410511 | 1 | 1 |
| 2023-01-18 | 424B5 | 424B5 | 0001193125-23-010269 | 333-260754 | 23535087 | 33 | 791168 | |||
| 2023-01-17 | 424B5 | 424B5 | 0001193125-23-009584 | 333-260754 | 23532312 | 33 | 796093 | |||
| 2023-01-17 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-23-009500 | 001-38978 | 23532050 | 34 | 166184 | 1 | 1 |
| 2023-01-13 | 4 | FORM 4 SUBMISSION | 0000899243-23-001803 | 4765 | ||||||
| 2023-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-001881 | 13313 | ||||||
| 2023-01-06 | SC 13G/A | SC 13G/A | 0001104659-23-001871 | 005-91080 | 23515464 | 34 | 73180 | |||
| 2023-01-04 | 8-K | 8-K | 2.02,5.02,8.01,9.01 | 0001193125-23-001193 | 001-38978 | 23504345 | 34 | 6277246 | 1 | 1 |
| 2022-12-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-130982 | 10970 | ||||||
| 2022-12-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-129121 | 10967 | ||||||
| 2022-12-16 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-127883 | 15121 | ||||||
| 2022-12-15 | 4 | FORM 4 SUBMISSION | 0000899243-22-038602 | 13220 | ||||||
| 2022-11-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-035434 | 5602 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0000899243-22-035433 | 8242 | ||||||
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-022913 | 001-38978 | 221367287 | 34 | 11733791 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-022910 | 001-38978 | 221367264 | 34 | 370095 | 1 | 1 |
| 2022-10-19 | 8-K | 8-K | 5.02 | 0001193125-22-265260 | 001-38978 | 221318704 | 34 | 142069 | 1 | 1 |
| 2022-08-26 | 3 | OWNERSHIP DOCUMENT | 0001104659-22-095159 | 9480 | ||||||
| 2022-08-26 | SC 13G | FULCRUM THERAPEUTICS, INC. | 0001104659-22-095158 | 005-91080 | 221205768 | 34 | 74102 | |||
| 2022-08-23 | 8-K | 8-K | 8.01 | 0001193125-22-227590 | 001-38978 | 221188169 | 34 | 143665 | 1 | 1 |
| 2022-08-17 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-222443 | 001-38978 | 221171488 | 34 | 431015 | 1 | 1 |
| 2022-08-17 | 424B5 | 424B5 | 0001193125-22-222439 | 333-260754 | 221171440 | 33 | 586339 | |||
| 2022-08-15 | 424B5 | 424B5 | 0001193125-22-221378 | 333-260754 | 221167515 | 33 | 590098 | |||
| 2022-08-11 | 4 | FORM 4 SUBMISSION | 0000899243-22-028370 | 5598 | ||||||
| 2022-08-11 | 4 | FORM 4 SUBMISSION | 0000899243-22-028368 | 5537 | ||||||
| 2022-08-11 | 3 | FORM 3 SUBMISSION | 0000899243-22-028366 | 11121 | ||||||
| 2022-08-11 | 10-Q | 10-Q | 0000950170-22-016644 | 001-38978 | 221153704 | 34 | 10690731 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-217954 | 001-38978 | 221153637 | 34 | 222841 | 1 | 1 |
| 2022-08-11 | 8-K | 8-K | 2.02,2.05,9.01 | 0000950170-22-016633 | 001-38978 | 221153617 | 34 | 354591 | 1 | 1 |
| 2022-07-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-026322 | 10049 | ||||||
| 2022-07-11 | 8-K | 8-K | 5.02 | 0001193125-22-191340 | 001-38978 | 221077538 | 34 | 144191 | 1 | 1 |
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-024528 | 12415 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-024525 | 10088 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-024524 | 10100 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-024527 | 5438 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-024526 | 10069 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-024523 | 10069 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-024522 | 10098 | ||||||
| 2022-06-22 | SC 13G | SCHEDULE 13G | 0000899140-22-000569 | 005-91080 | 221032222 | 34 | 67527 | |||
| 2022-06-10 | 8-K | 8-K | 8.01 | 0001193125-22-171957 | 001-38978 | 221009077 | 34 | 160817 | 1 | 1 |
| 2022-06-09 | 8-K | 8-K | 5.07 | 0001193125-22-171026 | 001-38978 | 221006017 | 34 | 152996 | 1 | 1 |
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-22-021530 | 9688 | ||||||
| 2022-06-06 | 4 | FORM 4 SUBMISSION | 0000899243-22-021250 | 26140 | ||||||
| 2022-06-06 | 8-K | 8-K | 1.02 | 0001193125-22-168375 | 001-38978 | 22998458 | 34 | 147012 | 1 | 1 |
| 2022-05-10 | 4 | FORM 4 SUBMISSION | 0000899243-22-017416 | 7560 | ||||||
| 2022-05-10 | 8-K | 8-K | 1.01,9.01 | 0001193125-22-145361 | 001-38978 | 22907141 | 34 | 379246 | 1 | 1 |
| 2022-05-10 | 424B5 | 424B5 | 0001193125-22-145358 | 333-260754 | 22907139 | 33 | 409896 | |||
| 2022-05-09 | POS EX | POS EX | 0001193125-22-145085 | 333-260754 | 22905837 | 33 | 32668 | |||
| 2022-05-09 | 10-Q | 10-Q | 0000950170-22-008235 | 001-38978 | 22903227 | 34 | 9803577 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008232 | 001-38978 | 22903205 | 34 | 295613 | 1 | 1 |
| 2022-04-28 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-22-063655,2022-04-28 | 9999999995-22-001133 | 333-260754 | 22869763 | 33 | 1688 | ||
| 2022-04-28 | DEFA14A | DEFA14A | 0001193125-22-127540 | 001-38978 | 22866544 | 34 | 387443 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0001193125-22-127507 | 001-38978 | 22866405 | 34 | 1447238 | |||
| 2022-04-11 | 4 | FORM 4 SUBMISSION | 0000899243-22-014438 | 9271 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-013881 | 21098 | ||||||
| 2022-03-14 | 3 | FORM 3 SUBMISSION | 0000899243-22-010854 | 11376 | ||||||
| 2022-03-10 | 8-K | 8-K | 5.02 | 0001193125-22-072011 | 001-38978 | 22729521 | 34 | 144315 | 1 | 1 |
| 2022-03-10 | SC 13G | FULCRUM THERAPEUTICS, INC. | 0000902664-22-002084 | 005-91080 | 22729456 | 34 | 107783 | |||
| 2022-03-09 | SC 13G | COWEN FINANCIAL PRODUCTS LLC | 0001085146-22-001221 | 005-91080 | 22724138 | 34 | 27122 | |||
| 2022-03-03 | POS AM | POS AM | 0001193125-22-063655 | 333-260754 | 22706769 | 33 | 386533 | |||
| 2022-03-03 | S-8 | S-8 | 0001193125-22-063643 | 333-263249 | 22706756 | 33 | 93276 | |||
| 2022-03-03 | 10-K | 10-K | 0000950170-22-002727 | 001-38978 | 22706727 | 34 | 13467653 | 1 | 1 | |
| 2022-03-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-002726 | 001-38978 | 22706714 | 34 | 343861 | 1 | 1 |
| 2022-03-03 | POSASR | POSASR | 0001193125-22-063344 | 333-260754 | 22706436 | 33 | 512458 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-042150 | 005-91080 | 22634414 | 34 | 197761 | |||
| 2022-02-14 | SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-22-001590 | 005-91080 | 22625534 | 34 | 60993 | |||
| 2022-02-11 | SC 13G/A | d9172507_13g-a.htm | 0000919574-22-000896 | 005-91080 | 22621277 | 34 | 107755 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001008 | 005-91080 | 22604309 | 34 | 8348 | |||
| 2022-02-04 | SC 13G | us3596161097_020422.txt | 0000834237-22-007149 | 005-91080 | 22593408 | 34 | 13227 | |||
| 2022-01-27 | S-8 | S-8 | 0001193125-22-018556 | 333-262356 | 22559350 | 33 | 77407 | |||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-002881 | 5400 | ||||||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-002880 | 5459 | ||||||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-002879 | 5452 | ||||||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-002878 | 5448 | ||||||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0000899243-22-002877 | 5385 | ||||||
| 2022-01-10 | 4 | FORM 4 SUBMISSION | 0000899243-22-001475 | 5545 | ||||||
| 2022-01-10 | 3 | FORM 3 SUBMISSION | 0000899243-22-001471 | 8158 | ||||||
| 2022-01-10 | 8-K | 8-K | 2.02,5.02,8.01,9.01 | 0001193125-22-005038 | 001-38978 | 22519657 | 34 | 197034 | 1 | 1 |
| 2022-01-07 | 5 | FORM 5 SUBMISSION | 0000899243-22-001356 | 4797 | ||||||
| 2022-01-04 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-001760 | 001-38978 | 22506726 | 34 | 179234 | 1 | 1 |
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-047542 | 5303 | ||||||
| 2021-12-09 | 3 | FORM 3 SUBMISSION | 0000899243-21-047522 | 8057 | ||||||
| 2021-12-06 | 8-K | 8-K | 8.01 | 0001193125-21-348354 | 001-38978 | 211471922 | 34 | 189654 | 1 | 1 |
| 2021-11-17 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-331947 | 001-38978 | 211418464 | 34 | 176126 | 1 | 1 |
| 2021-11-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-044427 | 9157 | ||||||
| 2021-11-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-044424 | 15506 | ||||||
| 2021-11-04 | S-3ASR | S-3ASR | 0001193125-21-319344 | 333-260754 | 211378054 | 33 | 1368335 | |||
| 2021-11-04 | 10-Q | 10-Q | 0001564590-21-054234 | 001-38978 | 211377986 | 34 | 9730145 | 1 | 1 | |
| 2021-11-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-054229 | 001-38978 | 211377958 | 34 | 336398 | 1 | 1 |
| 2021-09-27 | SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-21-009633 | 005-91080 | 211278864 | 34 | 24889 | |||
| 2021-09-24 | 4 | FORM 4 SUBMISSION | 0000899243-21-037615 | 9155 | ||||||
| 2021-09-24 | 4 | FORM 4 SUBMISSION | 0000899243-21-037614 | 15504 | ||||||
| 2021-09-10 | SC 13G/A | filing.txt | 0000315066-21-001729 | 005-91080 | 211246042 | 34 | 8349 | |||
| 2021-08-12 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-21-244795 | 001-38978 | 211168256 | 34 | 406272 | 1 | 1 |
| 2021-08-12 | 424B5 | 424B5 | 0001193125-21-244789 | 333-244136 | 211168219 | 33 | 543751 | |||
| 2021-08-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-032755 | 14441 | ||||||
| 2021-08-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-032753 | 14331 | ||||||
| 2021-08-11 | S-3MEF | S-3MEF | 0001193125-21-243764 | 333-258740 | 211165385 | 33 | 61231 | |||
| 2021-08-11 | 424B5 | 424B5 | 0001193125-21-242235 | 333-244136 | 211161587 | 33 | 546008 | |||
| 2021-08-10 | SC 13G | d8918002_13g.htm | 0000919574-21-004966 | 005-91080 | 211160928 | 34 | 123988 | |||
| 2021-08-10 | 10-Q | 10-Q | 0001564590-21-042876 | 001-38978 | 211158402 | 34 | 9421095 | 1 | 1 | |
| 2021-08-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-042873 | 001-38978 | 211158392 | 34 | 186688 | ||
| 2021-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-026557 | 4552 | ||||||
| 2021-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-026556 | 4489 | ||||||
| 2021-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-026555 | 4747 | ||||||
| 2021-06-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-026552 | 4478 | ||||||
| 2021-06-24 | 8-K | 8-K | 8.01 | 0001193125-21-198675 | 001-38978 | 211043018 | 34 | 35023 | ||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0000899243-21-023287 | 10034 | ||||||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0000899243-21-023288 | 10085 | ||||||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0000899243-21-023285 | 10068 | ||||||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0000899243-21-023286 | 5437 | ||||||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0000899243-21-023283 | 10076 | ||||||
| 2021-06-11 | 4 | FORM 4 SUBMISSION | 0000899243-21-023282 | 10051 | ||||||
| 2021-06-11 | 8-K | 8-K | 5.07 | 0001193125-21-188915 | 001-38978 | 211011698 | 34 | 23632 | ||
| 2021-05-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-019264 | 5601 | ||||||
| 2021-05-12 | 3 | FORM 3 SUBMISSION | 0000899243-21-019259 | 8351 | ||||||
| 2021-05-06 | 10-Q | 10-Q | 0001564590-21-024505 | 001-38978 | 21895740 | 34 | 7804856 | 1 | ||
| 2021-05-06 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-024502 | 001-38978 | 21895726 | 34 | 151553 | ||
| 2021-04-29 | DEFA14A | DEFA14A | 0001193125-21-138560 | 001-38978 | 21867412 | 34 | 397821 | |||
| 2021-04-29 | DEF 14A | DEF 14A | 0001193125-21-138549 | 001-38978 | 21867395 | 34 | 791845 | |||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014592 | 10077 | ||||||
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-014591 | 5611 | ||||||
| 2021-04-02 | 3 | FORM 3 SUBMISSION | 0000899243-21-014578 | 8263 | ||||||
| 2021-03-24 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-092672 | 001-38978 | 21768536 | 34 | 40990 | ||
| 2021-03-22 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000920 | 276148 | ||||||
| 2021-03-17 | 4 | FORM 4 SUBMISSION | 0000899243-21-012179 | 7497 | ||||||
| 2021-03-04 | S-8 | S-8 | 0001193125-21-068461 | 333-253862 | 21712567 | 33 | 59795 | |||
| 2021-03-04 | 10-K | 10-K | 0001564590-21-010715 | 001-38978 | 21712550 | 34 | 12274266 | 1 | ||
| 2021-03-04 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-21-068440 | 001-38978 | 21712542 | 34 | 116686 | ||
| 2021-02-24 | 4 | FORM 4 SUBMISSION | 0000899243-21-008015 | 13867 | ||||||
| 2021-02-22 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000614 | 277220 | ||||||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0000899243-21-007119 | 12155 | ||||||
| 2021-02-16 | SC 13G/A | SCHEDULE 13G (AMENDMENT #1) | 0000899140-21-000296 | 005-91080 | 21637021 | 34 | 52609 | |||
| 2021-02-16 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-023348 | 005-91080 | 21634325 | 34 | 75417 | |||
| 2021-02-12 | SC 13G/A | form-sc13ga.htm | 0001493152-21-003557 | 005-91080 | 21623740 | 34 | 192098 | |||
| 2021-02-11 | SC 13G/A | d8789595_13g-a.htm | 0000919574-21-000829 | 005-91080 | 21617350 | 34 | 127183 | |||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005666 | 5404 | ||||||
| 2021-02-10 | 3 | FORM 3 SUBMISSION | 0000899243-21-005661 | 12536 | ||||||
| 2021-02-08 | SC 13G/A | filing.txt | 0000315066-21-001009 | 005-91080 | 21599554 | 34 | 8303 | |||
| 2021-02-04 | 4 | FORM 4 SUBMISSION | 0000899243-21-004949 | 5462 | ||||||
| 2021-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-003474 | 5425 | ||||||
| 2021-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-003472 | 5400 | ||||||
| 2021-01-25 | 4 | FORM 4 SUBMISSION | 0000899243-21-003173 | 4904 | ||||||
| 2021-01-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-002928 | 5362 | ||||||
| 2021-01-20 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-21-012403 | 001-38978 | 21538814 | 34 | 210877 | ||
| 2021-01-20 | 424B5 | 424B5 | 0001193125-21-012394 | 333-244136 | 21538774 | 33 | 508044 | |||
| 2021-01-19 | 424B5 | 424B5 | 0001193125-21-011456 | 333-244136 | 21535618 | 33 | 511736 | |||
| 2021-01-19 | 8-K | 8-K | 2.02,5.02 | 0001193125-21-011438 | 001-38978 | 21535517 | 34 | 19671 | ||
| 2020-12-07 | 4 | FORM 4 SUBMISSION | 0000899243-20-032868 | 5305 | ||||||
| 2020-12-07 | 4 | FORM 4 SUBMISSION | 0000899243-20-032867 | 5548 | ||||||
| 2020-12-07 | 3 | FORM 3 SUBMISSION | 0000899243-20-032865 | 3547 | ||||||
| 2020-11-13 | SC 13G | formsc13g.htm | 0001493152-20-021235 | 005-91080 | 201309548 | 34 | 197944 | |||
| 2020-11-10 | 10-Q | 10-Q | 0001564590-20-052732 | 001-38978 | 201299618 | 34 | 8549541 | 1 | ||
| 2020-11-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-052728 | 001-38978 | 201299596 | 34 | 208117 | ||
| 2020-09-18 | SC 13G | SCHEDULE 13G | 0000899140-20-000435 | 005-91080 | 201184750 | 34 | 63753 | |||
| 2020-09-14 | 4 | FORM 4 SUBMISSION | 0000899243-20-024982 | 6935 | ||||||
| 2020-08-17 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-08-17 16:00:00 | 9999999995-20-002175 | 333-244136 | 201111625 | 33 | 1676 | ||
| 2020-08-13 | CORRESP | filename1.htm | 0001193125-20-219029 | 7099 | ||||||
| 2020-08-12 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-20-215674,2020-08-12 | 9999999995-20-002111 | 333-239353 | 201097017 | 33 | 1689 | ||
| 2020-08-12 | UPLOAD | filename1.pdf | 0000000000-20-007385 | 40256 | ||||||
| 2020-08-11 | POS AM | POS AM | 0001193125-20-215674 | 333-239353 | 201091085 | 33 | 253005 | |||
| 2020-08-11 | S-3 | S-3 | 0001193125-20-215668 | 333-244136 | 201091080 | 33 | 1498301 | |||
| 2020-08-11 | 10-Q | 10-Q | 0001564590-20-039121 | 001-38978 | 201091057 | 34 | 7710692 | 1 | ||
| 2020-08-11 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-039117 | 001-38978 | 201091042 | 34 | 199686 | ||
| 2020-07-23 | 8-K | 8-K | 1.01 | 0001193125-20-197820 | 001-38978 | 201043951 | 34 | 25579 |
One latest value per concept from companyfacts (212 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 76.38M | 2026-11-08 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 296.08M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065197 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 4.47M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-197196 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.64M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-197196 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 15,536 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-197196 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 0.72 | 2026-09-01 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 0.72 | 2026-09-01 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 5,225.1 | 2026-09-01 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-01 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-09-01 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 509,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 487,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -759,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 953.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.17M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 2.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 10.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | Assets | Assets | USD | 310.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 310.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 759,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 190.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 190.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | CapitalLeaseObligationsCurrent | Capital Lease Obligations, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 116.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 116.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 117.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -81.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 21.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 76.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 76.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 76,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -56.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 13.61M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-052732 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 5.96M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-052732 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 12.00M | 2026-06-30 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 190.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-052732 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 1.85M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021074 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 251,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021074 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 2.85M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 78.36M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.85M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 27.71M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 1.33M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 8.30M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 76.51M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | Depreciation | Depreciation | USD | 554,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | DividendIncomeOperatingPaidInCash | DividendIncomeOperatingPaidInCash | USD | 275.00M | 2026-08-16 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | Dividends | Dividends | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | DividendsCommonStock | Dividends, Common Stock | USD | 0 | 2015-08-19 | 2020-12-31 | 2020 | FY | 10-K/A | 2023-06-23 | 0000950170-23-029682 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.64 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008235 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.73 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 6.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 340,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 16.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | FinancingReceivableReclassificationToHeldForSale | Financing Receivable, Reclassification to Held-for-sale | USD | 900,000 | 2026-01-01 | 2026-06-30 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 24.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 |
| us-gaap | ImpairmentOfLeasehold | Impairment of Leasehold | USD | 1.30M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 7.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 20.72M | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -15.70M | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | -103,000 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 372,000 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -908,000 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021074 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -8.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026068 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -529,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 9.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 1.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 100,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 |
| us-gaap | LeaseIncentivePayableCurrent | Lease Incentive, Payable, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 17.11M | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 4.24M | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.42M | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 2.73M | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.65M | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.57M | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.50M | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 597,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054234 | |
| us-gaap | Liabilities | Liabilities | USD | 8.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 310.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 8.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 190.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 0 | 2019-12-31 | 2020 | FY | 10-K/A | 2023-06-23 | 0000950170-23-029682 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 242,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -33.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -48.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -56.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | NetIncomeLossAttributableToParentDiluted | Net Income (Loss) Attributable to Parent, Diluted | USD | -54.55M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-29 | 0001193125-25-254633 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -70.82M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K/A | 2023-06-23 | 0000950170-23-029682 |
| us-gaap | NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 | Noncash or Part Noncash Acquisition, Intangible Assets Acquired | USD | 25.50M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K/A | 2023-06-23 | 0000950170-23-029682 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 65.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -65.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 900,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 5.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 6.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 112.70M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026068 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 69,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-07-29 | 0000950170-25-099407 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 9,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -933,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -933,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 126,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 197,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 29,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008951 |
| us-gaap | PaymentsForOperatingActivities | Payments for Operating Activities | USD | 427,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 333,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 91,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K/A | 2023-06-23 | 0000950170-23-029682 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 179.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 116,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 7.13M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K/A | 2023-06-23 | 0000950170-23-029682 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 164.20M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 575,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 25.32M | 2018-01-01 | 2018-06-30 | 2019 | Q2 | 10-Q | 2019-08-26 | 0001564590-19-032952 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 47,000 | 2022-01-01 | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-15 | 0000950170-23-021960 |
| us-gaap | ProceedsFromRepurchaseOfRedeemablePreferredStock | Proceeds from (Repurchase of) Redeemable Preferred Stock | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 16.80M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-11 | 0001564590-20-039121 |
| us-gaap | ProceedsFromSaleOfMachineryAndEquipment | Proceeds from Sale of Machinery and Equipment | USD | 900,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -56.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | RepaymentsOfLongTermCapitalLeaseObligations | Repayments of Long-term Capital Lease Obligations | USD | 18,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029689 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 29.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 25.59M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K/A | 2023-06-23 | 0000950170-23-029682 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 1.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 1.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | RestructuringAndRelatedCostIncurredCost | Restructuring and Related Cost, Incurred Cost | USD | 4.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.85 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 4.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 4.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | RestructuringCostsAndAssetImpairmentCharges | Restructuring Costs and Asset Impairment Charges | USD | 54,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-022913 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 337,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -650.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 7.80M | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-022913 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 4.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 9.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 13.499 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 302.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.143 | 2019-07-04 | 2019-07-05 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008951 |
| us-gaap | StockIssued1 | Stock Issued | USD | 95,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 11.85M | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 76,718 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | -165.14M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008951 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeBenefitPlan | Stock Issued During Period, Value, Employee Benefit Plan | USD | 292,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 164.17M | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 0 | 2026-01-01 | 2026-03-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | StockRepurchasedAndRetiredDuringPeriodShares | Stock Repurchased and Retired During Period, Shares | shares | 9.35M | 2024-08-01 | 2024-08-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 0 | 2022-12-31 | 2022 | FY | 10-K/A | 2023-06-26 | 0000950170-23-029693 | |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 0 | 2023-06-30 | 2023 | Q1 | 10-Q | 2023-08-03 | 0000950170-23-037579 | |
| us-gaap | UnbilledReceivablesCurrent | Unbilled Receivables, Current | USD | 0 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued | Unrecognized Tax Benefits, Income Tax Penalties Accrued | USD | 0 | 2024-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued | Unrecognized Tax Benefits, Interest on Income Taxes Accrued | USD | 0 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | |||
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 0 | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 24.80M | 2025-01-01 | 2025-12-31 | S-4 | 2026-09-02 | 0001193125-26-379106 | ||
| us-gaap | VariableLeasePayment | Variable Lease, Payment | USD | 800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 76.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 40.64M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008235 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 76.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458453 |